{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:30:29Z","timestamp":1778200229842,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T00:00:00Z","timestamp":1429056000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1266-1","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T23:54:23Z","timestamp":1428969263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer"],"prefix":"10.1186","volume":"15","author":[{"given":"Francisco","family":"Beca","sequence":"first","affiliation":[]},{"given":"Miguel","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Jorge F","family":"Cameselle-Teijeiro","sequence":"additional","affiliation":[]},{"given":"Diana","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,4,15]]},"reference":[{"issue":"2","key":"1266_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1021\/cb700021z","volume":"2","author":"M Mumby","year":"2007","unstructured":"Mumby M. The 3D structure of protein phosphatase 2A: new insights into a ubiquitous regulator of cell signaling. ACS Chem Biol. 2007;2(2):99\u2013103.","journal-title":"ACS Chem Biol"},{"issue":"1","key":"1266_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2012.02.015","volume":"499","author":"A Kurimchak","year":"2012","unstructured":"Kurimchak A, Grana X. PP2A holoenzymes negatively and positively regulate cell cycle progression by dephosphorylating pocket proteins and multiple CDK substrates. Gene. 2012;499(1):1\u20137.","journal-title":"Gene"},{"issue":"3","key":"1266_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","volume":"139","author":"Y Shi","year":"2009","unstructured":"Shi Y. Serine\/threonine phosphatases: mechanism through structure. Cell. 2009;139(3):468\u201384.","journal-title":"Cell"},{"issue":"12","key":"1266_CR4","first-page":"3521","volume":"50","author":"M Suganuma","year":"1990","unstructured":"Suganuma M, Fujiki H, Furuya-Suguri H, Yoshizawa S, Yasumoto S, Kato Y, et al. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin. Cancer Res. 1990;50(12):3521\u20135.","journal-title":"Cancer Res"},{"issue":"1","key":"1266_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0092-8674(90)90726-U","volume":"60","author":"DC Pallas","year":"1990","unstructured":"Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL, et al. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell. 1990;60(1):167\u201376.","journal-title":"Cell"},{"issue":"4","key":"1266_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1158\/1535-7163.MCT-13-0150","volume":"13","author":"I Cristobal","year":"2014","unstructured":"Cristobal I, Manso R, Rincon R, Carames C, Senin C, Borrero A, et al. PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential. Mol Cancer Ther. 2014;13(4):938\u201347.","journal-title":"Mol Cancer Ther"},{"issue":"7513","key":"1266_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nature13600","volume":"512","author":"Y Wang","year":"2014","unstructured":"Wang Y, Waters J, Leung ML, Unruh A, Roh W, Shi X, et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature. 2014;512(7513):155\u201360.","journal-title":"Nature"},{"issue":"24","key":"1266_CR8","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1158\/0008-5472.CAN-12-1667","volume":"72","author":"P Kalev","year":"2012","unstructured":"Kalev P, Simicek M, Vazquez I, Munck S, Chen L, Soin T, et al. Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition. Cancer Res. 2012;72(24):6414\u201324.","journal-title":"Cancer Res"},{"issue":"11","key":"1266_CR9","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/leu.2011.146","volume":"25","author":"PP Ruvolo","year":"2011","unstructured":"Ruvolo PP, Qui YH, Coombes KR, Zhang N, Ruvolo VR, Borthakur G, et al. Low expression of PP2A regulatory subunit B55alpha is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patients. Leukemia. 2011;25(11):1711\u20137.","journal-title":"Leukemia"},{"issue":"25","key":"1266_CR10","doi-asserted-by":"publisher","first-page":"9157","DOI":"10.1073\/pnas.1317630111","volume":"111","author":"M Janghorban","year":"2014","unstructured":"Janghorban M, Farrell AS, Allen-Petersen BL, Pelz C, Daniel CJ, Oddo J, et al. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer. Proc Natl Acad Sci U S A. 2014;111(25):9157\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1266_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/cncr.24702","volume":"116","author":"WD Dupont","year":"2010","unstructured":"Dupont WD, Breyer JP, Bradley KM, Schuyler PA, Plummer WD, Sanders ME, et al. Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk. Cancer. 2010;116(1):8\u201319.","journal-title":"Cancer"},{"issue":"7403","key":"1266_CR12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352.","journal-title":"Nature"},{"issue":"5","key":"1266_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Canc Discov. 2012;2(5):401\u20134.","journal-title":"Canc Discov"},{"issue":"269","key":"1266_CR14","doi-asserted-by":"publisher","first-page":"l1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):l1.","journal-title":"Sci Signal"},{"issue":"5","key":"1266_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. Histopathology. 1991;19(5):403\u201310.","journal-title":"Histopathology"},{"issue":"3","key":"1266_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/jclinpath-2012-201169","volume":"66","author":"FF de Beca","year":"2013","unstructured":"de Beca FF, Caetano P, Gerhard R, Alvarenga CA, Gomes M, Paredes J, et al. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. J Clin Pathol. 2013;66(3):187\u201391.","journal-title":"J Clin Pathol"},{"issue":"9","key":"1266_CR17","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Panel m:Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24(9):2206\u201323.","journal-title":"Ann Oncol"},{"issue":"10","key":"1266_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MC Cheang","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101(10):736\u201350.","journal-title":"J Natl Cancer Inst"},{"issue":"31","key":"1266_CR19","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997\u20134013.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1266_CR20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ijc.25034","volume":"127","author":"PG Roy","year":"2010","unstructured":"Roy PG, Pratt N, Purdie CA, Baker L, Ashfield A, Quinlan P, et al. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. Int J Canc Suppl J Int Canc Suppl. 2010;127(2):355\u201360.","journal-title":"Int J Canc Suppl J Int Canc Suppl"},{"issue":"16","key":"1266_CR21","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.4161\/cc.25794","volume":"12","author":"D Martins","year":"2013","unstructured":"Martins D, Beca FF, Sousa B, Baltazar F, Paredes J, Schmitt F. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma. Cell Cycle. 2013;12(16):2684\u201390.","journal-title":"Cell Cycle"},{"issue":"1","key":"1266_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O","volume":"19","author":"M Mazumdar","year":"2000","unstructured":"Mazumdar M, Glassman JR. Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med. 2000;19(1):113\u201332.","journal-title":"Stat Med"},{"issue":"2","key":"1266_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10549-006-9242-8","volume":"100","author":"LM McShane","year":"2006","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumor marker prognostic studies (REMARK). Breast Cancer Res Treat. 2006;100(2):229\u201335.","journal-title":"Breast Cancer Res Treat"},{"issue":"9596","key":"1266_CR24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"issue":"9","key":"1266_CR25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/ncb2092","volume":"12","author":"MH Schmitz","year":"2010","unstructured":"Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, Ivanova E, et al. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol. 2010;12(9):886\u201393.","journal-title":"Nat Cell Biol"},{"issue":"38","key":"1266_CR26","doi-asserted-by":"publisher","first-page":"33029","DOI":"10.1074\/jbc.M111.253724","volume":"286","author":"M Alvarez-Fernandez","year":"2011","unstructured":"Alvarez-Fernandez M, Halim VA, Aprelia M, Laoukili J, Mohammed S, Medema RH. Protein phosphatase 2A (B55alpha) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A\/cyclin-dependent kinase-mediated phosphorylation. J Biol Chem. 2011;286(38):33029\u201336.","journal-title":"J Biol Chem"},{"issue":"4","key":"1266_CR27","first-page":"1077","volume":"60","author":"M Cuny","year":"2000","unstructured":"Cuny M, Kramar A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, et al. Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Res. 2000;60(4):1077\u201383.","journal-title":"Cancer Res"},{"issue":"2","key":"1266_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-007-9659-8","volume":"109","author":"S Elsheikh","year":"2008","unstructured":"Elsheikh S, Green AR, Aleskandarany MA, Grainge M, Paish CE, Lambros MB, et al. CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome. Breast Cancer Res Treat. 2008;109(2):325\u201335.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1266_CR29","first-page":"1177","volume":"2","author":"R Seshadri","year":"1996","unstructured":"Seshadri R, Lee CS, Hui R, McCaul K, Horsfall DJ, Sutherland RL. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin Canc Res. 1996;2(7):1177\u201384.","journal-title":"Clin Canc Res"},{"issue":"6","key":"1266_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/bjc.1996.128","volume":"73","author":"R Michalides","year":"1996","unstructured":"Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R, et al. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer. 1996;73(6):728\u201334.","journal-title":"Br J Cancer"},{"issue":"49","key":"1266_CR31","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1038\/sj.onc.1210506","volume":"26","author":"J Bostner","year":"2007","unstructured":"Bostner J, Ahnstrom Waltersson M, Fornander T, Skoog L, Nordenskjold B, Stal O. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Oncogene. 2007;26(49):6997\u20137005.","journal-title":"Oncogene"},{"issue":"17","key":"1266_CR32","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1158\/0008-5472.CAN-05-0746","volume":"65","author":"K Jirstrom","year":"2005","unstructured":"Jirstrom K, Stendahl M, Ryden L, Kronblad A, Bendahl PO, Stal O, et al. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification. Cancer Res. 2005;65(17):8009\u201316.","journal-title":"Cancer Res"},{"issue":"22","key":"1266_CR33","first-page":"708","volume":"141","author":"M Mrhalova","year":"2002","unstructured":"Mrhalova M, Kodet R, Strnad P. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection]. Cas Lek Cesk. 2002;141(22):708\u201314.","journal-title":"Cas Lek Cesk"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1266-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1266-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1266-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1266-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T10:55:41Z","timestamp":1717844141000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1266-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1266-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,15]]},"assertion":[{"value":"1 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"285"}}